Outlook Therapeutics Community
NasdaqCM:OTLK Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
Community Investing Ideas
RE
Community Contributor
Outlook Therapeutics will stay static with a 0% revenue change in the 5-year forecast
Rests on the FDA. With that said, OTLK was close to approval last round...
View narrativeUS$0
FV
n/aintrinsic discount0%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 month ago author updated this narrative